Nutex Health Income Statement (2010-2026) | NUTX

Income Statement Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter)
216.49M
Cost of Revenue (Quarter)
2.57M4.94M2.60M4.26M2.58M2.49M2.79M4.02M3.26M3.46M3.40M5.32M3.59M3.98M2.39M3.80M4.81M3.31M5.32M
Gross Profit (Quarter)
29.14M76.01M19.49M35.82M6.64M-26.47M0.53M4.85M9.65M7.07M13.21M10.16M22.56M21.92M141.63M118.34M124.92M154.88M46.14M
Operating items
Amortization - Intangibles (Quarter)
0.19M0.19M0.23M0.22M
Depreciation & Amortization - Total (Quarter)
Research & Development (Quarter)
0.06M0.07M0.08M0.07M
Selling, General & Administrative (Quarter)
14.38M
Restructuring Costs (Quarter)
3.55M3.89M0.01M0.04M536.00
Other Operating Expenses (Quarter)
-3.92M
Operating Expenses (Quarter)
1.53M1.55M3.95M43.31M8.02M402.21M53.19M9.29M49.28M7.89M56.46M57.30M53.52M12.25M27.42M37.68M119.06M24.51M277.54M
Operating Income (Quarter)
81.27M
EBIT (Quarter)
81.27M
Non-operating items
Non Operating Investment Income (Quarter)
Interest & Investment Income (Quarter)
245.00270.00288.00368.00
Other Non Operating Income (Quarter)
-0.02M
Non Operating Income (Quarter)
4.06M1.75M-0.24M1.50M1.40M0.63M-0.21M-0.25M7.24M9.54M-0.33M0.24M7.50M-0.13M-0.04M11.04M-4.27M-0.98M
Net income details
EBT (Quarter)
76.56M
Tax Provisions (Quarter)
13.80M
Profit After Tax (Quarter)
29.68M74.49M13.47M24.83M-24.00M-412.19M-10.66M-6.92M-4.27M-5.54M-27.71M-0.54M3.01M-8.79M99.97M50.81M16.14M55.44M121.40M
Income from Non-Controlling Interests (Quarter)
2.62M20.70M-0.50M-0.63M-4.71M-10.72M4.09M-1.77M-0.79M1.02M3.91M-0.18M3.37M1.62M38.27M29.59M33.84M41.36M4.77M
Income from Continuing Operations (Quarter)
62.76M
Consolidated Net Income (Quarter)
62.76M
Income towards Parent Company (Quarter)
62.76M
Net Income towards Common Stockholders (Quarter)
23.71M-2.29M65.42M7.18M-19.40M-422.52M9.93M-6.92M-4.27M-4.52M-27.71M-0.36M3.01M-7.17M100.05M14.63M16.14M96.80M16.61M
Additional items
EPS (Basic) (Quarter)
0.050.090.020.04-0.03-0.63-0.02-0.12-0.79-1.25-7.47-0.08-0.07-1.7211.833.74-2.958.271.50
EPS (Weighted Average and Diluted) (Quarter)
0.050.090.020.04-0.03-0.63-0.02-0.12-0.79-1.25-7.47-0.08-0.07-1.7211.123.33-2.957.761.61
Shares Outstanding (Weighted Average) (Quarter)
6.99M
Shares Outstanding (Diluted Average) (Quarter)
592.79M626.99M
EBITDA (Quarter)
81.27M
Interest Expenses (Quarter)
4.68M
Tax Rate (Quarter)
1.60%0.61%-0.95%0.71%-452.33%1.98%-20.39%11.63%16.05%7.03%9.76%-256.58%22.90%-177.71%7.92%28.66%31.97%21.90%35.86%